Investing News
Life Style
Market News
Medical Use
Pharmaceutical
Products
The Market Buzz
Your Environment
J&J Predicts Over $3 Billion in 2022 Covid Vaccine Sales
Johnson & Johnson (NYSE: JNJ) announced expectations for its Covid vaccine to produce USD3 Billion to USD3.5 Billion in sales throughout 2022. The prediction comes after it posted mixed...